Nitrobenzyl derivatives of anti-cancer agents
US10829437B2 · kind B2 · utility
0Cited by
3References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 1, 2016 |
| Grant date | Nov 10, 2020 |
| Priority date | — |
| Expiry date | Apr 1, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/54
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compounds of formula I, wherein the variables are defined herein, processes of making them, and methods of treating cancer comprising administering such compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.